PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Morgan ET. Drug Metab Dispos. Feb 2008; 36(2): 205-16 Pubmed [12834]
Morgan ND. J Clin Rheumatol. Aug 2013; 19(5): 286-8 Pubmed [8504]
Morganroth J. Expert Opin Pharmacother. Jan 2013; 14(1): 5-13 Pubmed [8849]
Mori H. United European Gastroenterol J. Jun 2016; 4(3): 380-7 Pubmed, Volltext, DOI [8236]
Mori M. Indian J Pharmacol. Nov 2014; 46(6): 657-9 Pubmed, Volltext, DOI [3938]
Morii H. J Pain Symptom Manage. Jan 2007; 33(1): 5-6 Pubmed [6084]
Morikawa K. Drug Des Devel Ther. Sep 2018; 12: 2749-2756 Pubmed, Volltext, DOI [8414]
Morimoto T. J Clin Pharmacol. Jan 2004; 44(1): 95-101 Pubmed [1570]
Morival C. Eur J Clin Pharmacol. Apr 2018; 74(4): 525-534 Pubmed [8211]
Morlet-Barla N. Presse Med. Jul 2000; 29(24): 1351 Pubmed [5336]
Moro H. AIDS Patient Care STDS. Dec 2004; 18(12): 687-90 Pubmed [5915]
Morón B. Am J Gastroenterol. Aug 2013; 108(8): 1344-51 Pubmed [3734]
Morris DJ. Drug Saf. Apr 1994; 10(4): 281-91 Pubmed [4962]
Morris DW. Ann Fam Med. Jan 2012; 10(1): 23-33 Pubmed, Volltext, DOI [3523]
Morris MI. Am J Health Syst Pharm. Feb 2009; 66(3): 225-36 Pubmed [6778]
Morrison D. PLoS One. Dec 2007; 2(12): e1305 Pubmed, Volltext, DOI [7316]
Morrison EK. J Clin Pharm Ther. Oct 2012; 37(5): 610-3 Pubmed [5250]
Morrison G. Clin Pharmacol Drug Dev. Nov 2019; 8(8): 1009-1031 Pubmed, Volltext, DOI [9380]
Morrissey KM. Annu Rev Pharmacol Toxicol. Jan 2013; 53: 503-29 Pubmed [7415]
Morschel CF. J Bras Nefrol. Jul 2018; 40(3): 301-306 Pubmed [11192]
Morse GD. Antimicrob Agents Chemother. Aug 2005; 49(8): 3373-81 Pubmed, Volltext, DOI [6314]
Mort JR. Pharmacotherapy. Sep 2006; 26(9): 1307-13 Pubmed [10790]
Morton E. CNS Drugs. Apr 2021; 35(4): 439-450 Pubmed [12913]
Moschny N. Pharmaceuticals (Basel). May 2021; 14(6) Pubmed, Volltext, DOI [10718]
Moseley BD. Epilepsy Res. Dec 2019; 158: 106218 Pubmed [9430]
Moseley BD. Epilepsy Res. Jul 2020; 163: 106327 Pubmed [9453]
Mosholder AD. Ann Pharmacother. Nov 2013; 47(11): 1420-8 Pubmed [7080]
Moskaleva NE. J Pharm Biomed Anal. May 2017; 138: 118-125 Pubmed [9570]
Moskowitz H. Prog Neuropsychopharmacol Biol Psychiatry. Jan 1988; 12(5): 783-92 Pubmed [1351]
Moss AJ. Am J Cardiol. Aug 1993; 72(6): 23B-25B Pubmed [3667]
Moss AJ. Drug Saf. Jan 1999; 21 Suppl 1: 69-80; discussion 81-7 Pubmed [8582]
Moss JH. Can J Psychiatry. Dec 1986; 31(9): 865-6 Pubmed [2170]
Moss MJ. J Clin Psychopharmacol. Nov 2019; 39(6): 628-633 Pubmed [9624]
Mostafaei H. Eur Urol Focus. Sep 2021 Pubmed [12463]
Mostafavi A. Acta Med Iran. Jan 2014; 52(10): 734-9 Pubmed [3903]
Mota CR. Eur J Pediatr. Apr 1996; 155(4): 345 Pubmed [5990]
Motilium Fachinformation [1107]
Mould DR. BioDrugs. Feb 2010; 24(1): 23-39 Pubmed [4236]
Moultrie H. J Antimicrob Chemother. Feb 2015; 70(2): 543-9 Pubmed, Volltext, DOI [8729]
Mouly S. Pharmacol Res. Apr 2017; 118: 82-92 Pubmed [4628]
Mounzer K. AIDS Res Ther. Jan 2019; 16(1): 1 Pubmed, Volltext, DOI [7264]
Mouroux M. J Clin Microbiol. Jul 2000; 38(7): 2726-30 Pubmed, Volltext [7428]
Moustafa Ma, Babhair SA, Kouta HI. Decreased bioavailability of some antipsychotic phenothiazines due to interactions with adsorbent antacid and antidiarrhoel mixtures. Int J Pharmaceutics (1987) 36, 185-9 [1416]
Mowla A. Pharmacopsychiatry. Sep 2009; 42(5): 204-5 Pubmed [1381]
Moyle GJ. Br J Clin Pharmacol. Aug 2002; 54(2): 178-82 Pubmed, Volltext, DOI [6773]
Moyle J. J Pain Symptom Manage. Nov 1995; 10(8): 643-6 Pubmed [7505]
Mozaffar M. J Res Pharm Pract. Jul 2016; 5(3): 212-4 Pubmed, Volltext, DOI [7319]
Mrazek DA. Pharmacogenet Genomics. Jan 2011; 21(1): 1-9 Pubmed, Volltext [3565]
Mu Y. Expert Opin Pharmacother. Mar 2020; 21(4): 389-397 Pubmed [8381]
Mück W. Clin Pharmacokinet. Aug 2000; 39(2): 99-116 Pubmed [344]
Mück-Seler D. J Affect Disord. Nov 1991; 23(3): 157-64 Pubmed [11244]
Muddam MR. Cureus. Sep 2023; 15(9): e45560 Pubmed [13500]
Mueck W. Br J Clin Pharmacol. Sep 2013; 76(3): 455-66 Pubmed, Volltext, DOI [5052]
Mueck W. Clin Pharmacokinet. Jan 2014; 53(1): 1-16 Pubmed, Volltext, Springer [4977]
Mueck W. Thromb Haemost. Sep 2008; 100(3): 453-61 Pubmed [4978]
Muehlan C. Expert Opin Drug Metab Toxicol. Nov 2020; 16(11): 1063-1078 Pubmed [12713]
Mueller BU. J Pediatr. Jul 1994; 125(1): 142-6 Pubmed [6714]
Mueller SC. Eur J Clin Pharmacol. Jan 2006; 62(1): 29-36 Pubmed [13368]
Mueller SC. Eur J Clin Pharmacol. Jan 2009; 65(1): 81-7 Pubmed [2816]
Muilwijk EW. Antimicrob Agents Chemother. Aug 2017; 61(9) Pubmed [13065]
Muirhead GJ. Br J Clin Pharmacol. Aug 2000; 50(2): 99-107 Pubmed, Volltext, DOI [6362]
Muirhead GJ. Br J Clin Pharmacol. Jan 2002; 53 Suppl 1: 37S-43S Pubmed, Volltext, DOI [2878]
Mukai H. Invest New Drugs. Jun 2017; 35(3): 307-314 Pubmed [11568]
Mukherjee A. Indian J Pediatr. May 2019; 86(5): 468-478 Pubmed [8396]
Mukherjee D. J Pharmacokinet Pharmacodyn. Jun 2018; 45(3): 443-456 Pubmed, Volltext, Springer [6487]
Mukherjee N. et al. Journal of Pharmacy Research | Vol 11 • Issue 9 • 2017. Sep 2017; 11(9) Pubmed [11642]
Mukherjee N. et al. Journal of Pharmacy Research. Sep 2017; 11 Pubmed [11643]
Mulangu S. N Engl J Med. Dec 2019; 381(24): 2293-2303 Pubmed [8600]
Müller et al. Lancet (1988) ii, 1500 [1153]
Müller H. Singapore Med J. Nov 2012; 53(11): e228-30 Pubmed [3986]
Müller T. Cells. Apr 2022; 11(9) Pubmed [12189]
Müller T. Clin Pharmacokinet. Mar 2017; 56(3): 251-261 Pubmed [12177]
Müller T. Clin Pharmacol. Apr 2018; 10: 31-41 Pubmed [12224]
Müller T. Drugs Today (Barc). Nov 2015; 51(11): 653-9 Pubmed [12240]
Müller T. Lancet. Dec 1988; 2(8626-8627): 1500 Pubmed [1074]
Müller T. Neurodegener Dis Manag. Aug 2020; 10(4): 195-204 Pubmed [12180]
Müller T. Ther Clin Risk Manag. Aug 2016; 12: 1151-60 Pubmed [12241]
Müller T. Transl Neurodegener. May 2012; 1(1): 10 Pubmed, Volltext, DOI [4585]
Müller WE. Pharmacopsychiatry. Nov 2004; 37 Suppl 3: S189-97 Pubmed [3299]
Müller-Oerlinghausen B, Greil W, Berghöfer A (Hrsg.), Die Lithiumtherapie, Nutzen, Risiken, Alternativen, 2.Aufl. 1997, Springer Berlin-Heidelberg, S. 450-1 [1708]
Müller-Oerlinghausen B, Unerwünschte Wechselwirkung von Lithiumsalzen mit anderen Arzneimitteln. In: Die Lithiumtherapie: Nutzen, Risiken, Alternativen, Hrsg.: B.Müller-Oerlinghausen et al., 2. Aufl. Springer (Berlin, Heidelberg) 1997, 361-381 [2557]
Müller-Oerlinghausen, Unerwünschte Wechselwirkung von Lithiumsalzen mit anderen Arzneimitteln in: Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Hrsg.: B.Müller-Oerlinghausen et al., Springer (Berlin, Heidelberg) 1997, 446-455 [2762]
Müller-Siecheneder F. J Clin Psychopharmacol. Apr 1998; 18(2): 111-20 Pubmed [671]
Mulley et al. J Clin Pharm (1978) 3, 25-35 [1280]
Mumenthaler MS. Neuropsychopharmacology. Jul 2003; 28(7): 1366-73 Pubmed [3302]
Muñana KR. J Vet Intern Med. Sep 2018; 32(5): 1677-1683 Pubmed, Volltext, DOI [9422]
Munhoz RP. Clin Neuropharmacol. Sep 2004; 27(5): 219-22 Pubmed [2281]
Muñoz-Pacheco P. J Hypertens. Nov 2013; 31(11): 2309-18; discussion 2319 Pubmed [12673]
Muñoz-Pichuante D. Drug Metab Pers Ther. Jun 2020; 35(2) Pubmed [11131]
Murai K. Xenobiotica. Nov 2009; 39(11): 795-802 Pubmed [3078]
Muraro L. J Anesth. Oct 2016; 30(5): 895-9 Pubmed [4262]
Murphy L. J Pain Res. Nov 2015; 8: 851-7 Pubmed, Volltext [9632]
Murphy MD. Clin Infect Dis. Apr 2003; 36(8): 1082-5 Pubmed [5677]
Murphy PA. Contraception. Jun 2005; 71(6): 402-8 Pubmed [1562]
Murphy R. Ann Intern Med. Nov 1990; 113(10): 799-800 Pubmed [6805]
Murphy RA. J Pharmacol Exp Ther. Nov 2017; 363(2): 156-163 Pubmed [7862]
Murphy RL. J Infect Dis. May 1999; 179(5): 1116-23 Pubmed [6907]
Murray S. Xenobiotica. Mar 2001; 31(3): 135-51 Pubmed [355]
Murry DJ. J Pediatr Hematol Oncol. Feb 2002; 24(2): 130-3 Pubmed [13426]
Muscatello et al. (2000) Epilepsia 46:771-774 [2802]